AACR20: the future of immunotherapy in solid tumors, an interview with Mihaela Cristea

Written by Mihaela Cristea (City of Hope, CA, USA)

Recently, we interviewed Mihaela Cristea (City of Hope, CA, USA) about her work presented at the American Association for Cancer Research Virtual Annual Event I (AACR; 27–28 April 2020). Cristea discusses the use of T cells in solid tumors and the challenges and implications of immunotherapy. Please could you introduce yourself, your research backgrounds and your research interests? I am a medical oncologist and have been at City of Hope since 2005. My experience in clinical research started in lung cancer. Eventually, I transitioned into gynecologic medical oncology and now focus primarily on ovarian cancer. In terms of research interests, initially...

To view this content, please register now for access

It's completely free